Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Curry

Showing results (211-220 of 247) with videos related to

Pageof 25
Sort By:
Journal of the National Cancer Institute|October 27, 2015
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted TherapyPriscilla K Brastianos, Ganesh M Shankar, Corey M Gill, et al.
Neuro-Oncology|January 25, 2026
Cognitive Function, Quality of Life, and Survival Outcomes in Patients with Lower Grade Gliomas Treated with Proton Radiation Therapy: A Phase II studyJason M Slater, Nora K Horick, Lisa B Nachtigall, et al.
Nature Biotechnology|July 24, 2019
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicityBryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Cancer Discovery|August 21, 2014
Brain tumor cells in circulation are enriched for mesenchymal gene expressionJames P Sullivan, Brian V Nahed, Marissa W Madden, et al.
JAMA Cardiology|March 31, 2025
Leveraging Preexisting Cardiovascular Data to Improve the Detection and Treatment of Hypertension: The NOTIFY-LVH Randomized Clinical TrialAdam N Berman, Michael K Hidrue, Curtis Ginder, et al.
Journal of Neurosurgery|May 6, 2022
The New England Neurosurgical Society: growth and evolution over 70 yearsAndy Y Wang, Vaishnavi Sharma, Wenya Linda Bi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2022
Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed GlioblastomaManmeet S Ahluwalia, David A Reardon, Ajay P Abad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2019
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with GlioblastomaPatrick Y Wen, David A Reardon, Terri S Armstrong, et al.
Acta Neuropathologica|October 22, 2015
BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histologyGanesh M Shankar, Nina Lelic, Corey M Gill, et al.
Neuro-Oncology Advances|February 8, 2023
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastomaAndrea Schmidts, Ambike A Srivastava, Rishab Ramapriyan, et al.
Pageof 25

Showing results (211-220 of 247) with videos related to

Sort By:
Pageof 25
Journal of the National Cancer Institute|October 27, 2015
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted TherapyPriscilla K Brastianos, Ganesh M Shankar, Corey M Gill, et al.
Neuro-Oncology|January 25, 2026
Cognitive Function, Quality of Life, and Survival Outcomes in Patients with Lower Grade Gliomas Treated with Proton Radiation Therapy: A Phase II studyJason M Slater, Nora K Horick, Lisa B Nachtigall, et al.
Nature Biotechnology|July 24, 2019
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicityBryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Cancer Discovery|August 21, 2014
Brain tumor cells in circulation are enriched for mesenchymal gene expressionJames P Sullivan, Brian V Nahed, Marissa W Madden, et al.
JAMA Cardiology|March 31, 2025
Leveraging Preexisting Cardiovascular Data to Improve the Detection and Treatment of Hypertension: The NOTIFY-LVH Randomized Clinical TrialAdam N Berman, Michael K Hidrue, Curtis Ginder, et al.
Journal of Neurosurgery|May 6, 2022
The New England Neurosurgical Society: growth and evolution over 70 yearsAndy Y Wang, Vaishnavi Sharma, Wenya Linda Bi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2022
Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed GlioblastomaManmeet S Ahluwalia, David A Reardon, Ajay P Abad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2019
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with GlioblastomaPatrick Y Wen, David A Reardon, Terri S Armstrong, et al.
Acta Neuropathologica|October 22, 2015
BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histologyGanesh M Shankar, Nina Lelic, Corey M Gill, et al.
Neuro-Oncology Advances|February 8, 2023
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastomaAndrea Schmidts, Ambike A Srivastava, Rishab Ramapriyan, et al.
Pageof 25